Violetta Faryno, MD
Obstetrics/Gynecology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 32
- 8 carriers
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
32 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Faryno’s office at (408) 288-9933 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
32 of 32 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A50343 · Current
Licensed to practise in California · since 1992 · expires 2028-01-31 · Medical Academy of Warsaw.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$19,120
Medicare paid this office $19,120 for 149 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 130 | $7,462 | $57 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 132 | $6,319 | $48 |
| Return visit (30+ min) | 25 | $2,704 | $93 |
Who their Medicare patients are
149 Original Medicare patients in 2024. Average age 72 · Women 100% · Health risk score 0.72. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 62% · Diabetes 26% · Coronary heart disease 13% · Cancer 13% · Depression 13% · Chronic kidney disease 10%.
The office billed $28,490, Medicare allowed $21,622 and paid $19,120; for 310 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 149 | 310 | 72 | 0.72 | $28,490 | $19,120 |
| 2023 | 126 | 260 | 73 | 0.68 | $26,505 | $16,719 |
| 2022 | 138 | 283 | 74 | 0.74 | $34,605 | $20,940 |
| 2021 | 130 | 296 | 73 | 0.87 | $35,775 | $22,033 |
| 2020 | 150 | 382 | 74 | 0.76 | $48,618 | $26,601 |
| 2019 | 136 | 327 | 73 | 0.83 | $42,152 | $26,533 |
| 2018 | 138 | 324 | 72 | 0.86 | $42,023 | $24,136 |
| 2017 | 94 | 223 | 72 | 0.76 | $24,708 | $14,486 |
| 2016 | 153 | 352 | 72 | 0.85 | $36,231 | $24,869 |
| 2015 | 140 | 332 | 74 | 0.86 | $27,272 | $21,804 |
| 2014 | 120 | 265 | 73 | 0.82 | $20,036 | $15,984 |
| 2013 | 143 | 312 | 73 | 0.92 | $24,253 | $19,934 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 104 | $5,812 | $56 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 103 | $4,922 | $48 |
| Return visit (30+ min) | 28 | $3,259 | $105 |
2022: 4 services
| Return visit (30+ min) | 37 | $7,154 | $114 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 95 | $5,223 | $55 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 93 | $4,434 | $48 |
| New patient visit (45+ min) | 15 | $1,914 | $128 |
2021: 5 services
| Return visit (30+ min) | 44 | $7,406 | $112 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 88 | $4,906 | $56 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 87 | $4,218 | $48 |
| New patient visit (45+ min) | 16 | $2,414 | $151 |
| Short return visit (20+ min) | 15 | $1,142 | $76 |
2020: 3 services
| Return visit (30+ min) | 130 | $14,230 | $84 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 87 | $4,752 | $55 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 91 | $4,295 | $47 |
2019: 4 services
| Return visit (30+ min) | 117 | $13,931 | $95 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 70 | $3,774 | $54 |
| New patient visit (45+ min) | 22 | $3,281 | $149 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 66 | $3,023 | $46 |
2018: 4 services
| Return visit (30+ min) | 120 | $13,690 | $85 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 53 | $2,843 | $54 |
| New patient visit (45+ min) | 23 | $2,773 | $121 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 55 | $2,432 | $44 |
2017: 3 services
| Return visit (30+ min) | 86 | $8,238 | $78 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 47 | $2,433 | $52 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 45 | $1,926 | $43 |
2016: 4 services
| Return visit (30+ min) | 103 | $12,243 | $87 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 80 | $4,253 | $53 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 79 | $3,438 | $44 |
| New patient visit (45+ min) | 23 | $2,888 | $126 |
2015: 5 services
| Return visit (30+ min) | 49 | $6,621 | $92 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 92 | $4,921 | $53 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 91 | $3,985 | $44 |
| New patient visit (45+ min) | 13 | $1,796 | $138 |
| Short return visit (20+ min) | 23 | $1,748 | $60 |
2014: 4 services
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 81 | $4,335 | $54 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 83 | $3,654 | $44 |
| Return visit (30+ min) | 29 | $3,185 | $86 |
| Short return visit (20+ min) | 18 | $1,461 | $54 |
2013: 5 services
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 107 | $5,956 | $56 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 104 | $4,689 | $45 |
| Return visit (30+ min) | 24 | $3,456 | $91 |
| New patient visit (45+ min) | 16 | $2,150 | $134 |
| Short return visit (20+ min) | 15 | $1,130 | $59 |
Drugs they prescribed that Part D paid
$14,537
Pharmacies billed $14,537 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 241) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
207 generic and 34 brand-name prescriptions · $14,537 in drug cost · 25 antibiotic prescriptions to 17 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Prempro | 13 | $3,194 | $246 |
| Progesterone | 36 | $2,248 | $62 |
| Estradiol | 33 | $812 | $25 |
| Terconazole | 24 | $477 | $20 |
| Nitrofurantoin Mono-Macro | 14 | $140 | $10 |
See all 7 drugs
| Prempro | 13 | $3,194 | $246 |
| Progesterone | 36 | $2,248 | $62 |
| Estradiol | 33 | $812 | $25 |
| Terconazole | 24 | $477 | $20 |
| Nitrofurantoin Mono-Macro | 14 | $140 | $10 |
| Fluconazole | 19 | $138 | $7 |
| Clobetasol Propionate | 13 | $44 | $3 |
Year by year
| 2024 | 241 | 69 | 0% (0) | 14% | $14,537 |
| 2023 | 192 | 60 | 0% (0) | 28% | $15,277 |
| 2022 | 179 | 63 | None | 35% | $14,157 |
| 2021 | 151 | 44 | 0% (0) | 26% | $14,974 |
| 2020 | 177 | 56 | None | 28% | $18,551 |
| 2019 | 173 | 55 | None | 28% | $16,180 |
| 2018 | 191 | 59 | None | 28% | $16,501 |
| 2017 | 167 | 48 | None | 28% | $11,084 |
| 2016 | 190 | 54 | None | 31% | $18,128 |
| 2015 | 236 | 57 | None | None | $23,118 |
| 2014 | 211 | 47 | None | 45% | $24,073 |
| 2013 | 204 | 54 | None | 43% | $16,261 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Prempro | 13 | $3,339 | $257 |
| Progesterone | 23 | $2,352 | $102 |
| Lyllana | 12 | $1,926 | $160 |
| Estradiol | 22 | $660 | $30 |
| Terconazole | 15 | $428 | $29 |
| Nitrofurantoin Mono-Macro | 15 | $219 | $15 |
| Misoprostol | 11 | $19 | $2 |
2022: 5 drugs
| Prempro | 13 | $3,116 | $240 |
| Progesterone | 13 | $1,235 | $95 |
| Estradiol | 21 | $1,128 | $54 |
| Nitrofurantoin Mono-Macro | 16 | $319 | $20 |
| Misoprostol | 21 | $49 | $2 |
2021: 3 drugs
| Prempro | 13 | $2,966 | $228 |
| Terconazole | 14 | $424 | $30 |
| Nitrofurantoin Mono-Macro | 16 | $282 | $18 |
2020: 3 drugs
| Prempro | 13 | $2,805 | $216 |
| Progesterone | 11 | $1,119 | $102 |
| Nitrofurantoin Mono-Macro | 15 | $269 | $18 |
2019: 3 drugs
| Prempro | 13 | $2,682 | $206 |
| Nitrofurantoin Mono-Macro | 14 | $246 | $18 |
| Misoprostol | 11 | $21 | $2 |
2018: 6 drugs
| Prempro | 14 | $3,119 | $223 |
| Premarin | 12 | $2,073 | $173 |
| Terconazole | 16 | $544 | $34 |
| Nitrofurantoin Mono-Macro | 13 | $389 | $30 |
| Fluconazole | 14 | $213 | $15 |
| Mupirocin | 12 | $175 | $15 |
2017: 5 drugs
| Premarin | 15 | $2,926 | $195 |
| Premphase | 11 | $1,980 | $180 |
| Progesterone | 12 | $440 | $37 |
| Estradiol | 15 | $168 | $11 |
| Fluconazole | 15 | $114 | $8 |
2016: 6 drugs
| Premphase | 13 | $2,071 | $159 |
| Premarin | 12 | $1,623 | $135 |
| Terconazole | 11 | $295 | $27 |
| Progesterone | 12 | $281 | $23 |
| Estradiol | 14 | $243 | $17 |
| Alprazolam | 14 | $123 | $9 |
2015: 10 drugs
| Desonide | 18 | $3,068 | $170 |
| Vagifem | 11 | $2,693 | $245 |
| Premphase | 13 | $1,727 | $133 |
| Premarin | 15 | $1,716 | $114 |
| Terconazole | 17 | $561 | $33 |
| Nitrofurantoin Mono-Macro | 12 | $375 | $31 |
| Progesterone | 14 | $345 | $25 |
| Alprazolam | 12 | $244 | $20 |
| Estradiol | 12 | $229 | $19 |
| Fluconazole | 14 | $70 | $5 |
2014: 8 drugs
| Raloxifene | 12 | $3,533 | $294 |
| Premarin | 18 | $2,928 | $163 |
| Premphase | 12 | $1,363 | $114 |
| Vivelle-Dot | 13 | $1,095 | $84 |
| Vagifem | 11 | $1,060 | $96 |
| Progesterone | 12 | $515 | $43 |
| Terconazole | 14 | $465 | $33 |
| Necon | 11 | $223 | $20 |
2013: 8 drugs
| Evista | 16 | $4,223 | $264 |
| Estrace | 12 | $1,730 | $144 |
| Vagifem | 18 | $1,602 | $89 |
| Premphase | 13 | $1,256 | $97 |
| Desonide | 12 | $1,003 | $84 |
| Vivelle-Dot | 12 | $869 | $72 |
| Terconazole | 21 | $555 | $26 |
| Cyclafem | 11 | $226 | $21 |
Money from drug and device companies
$61 in 2025
| 2025 | 1 | 5 | None | $61 |
| 2024 | 1 | 21 | None | $299 |
| 2023 | 1 | 26 | None | $249 |
| 2022 | 1 | 19 | None | $124 |
| 2021 | 3 | 42 | None | $405 |
| 2020 | 2 | 9 | None | $150 |
| 2019 | 4 | 9 | None | $153 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Mayne Pharma Commercial | None | $61 | 5 payments
|
See all 5 published payments
| Mayne Pharma Commercial | Meals · 2025-05-01 | None | $10 |
| Mayne Pharma Commercial | Meals · 2025-03-31 | None | $12 |
| Mayne Pharma Commercial | Meals · 2025-03-10 | None | $7 |
| Mayne Pharma Commercial | Meals · 2025-02-20 | None | $25 |
| Mayne Pharma Commercial | Meals · 2025-01-23 | None | $7 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $299
| Mayne Pharma Commercial | None | $299 | 21 payments
|
2023: $249
| Mayne Pharma Commercial | None | $249 | 26 payments
|
2022: $124
| TherapeuticsMD | Annovera | $124 | 19 payments
|
2021: $405
| AbbVie | Lo Loestrin Fe | $233 | 17 payments
|
| TherapeuticsMD | Annovera | $129 | 22 payments
|
| Avion Pharmaceuticals | Balcoltra | $43 | 3 payments
|
2020: $150
| Avion Pharmaceuticals | Balcoltra | $109 | 7 payments
|
| AbbVie | Liletta | $40 | 2 payments
|
2019: $153
| TherapeuticsMD | Bijuva | $53 | 2 payments
|
| Avion Pharmaceuticals | Prenate Mini | $44 | 3 payments
|
| Mission Pharmacal | Citranatal | $38 | 3 payments
|
| Hologic | Thinprep | $19 | 1 payment
|
Professional record
- NPI
- 1285650911
- Licence
- CA A50343California A50343: Current · expires 2028-01-31
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- Po Box 70, Los Altos, CA, 94023
- NPI first listed
- 2006-07-14
- NPI last updated
- 2020-01-17
- NPI record certified
- 2020-01-17
This is when the NPI record was last certified, not a medical board exam.